We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cardiogenomics Registry (CGR)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00861575
First Posted: March 13, 2009
Last Update Posted: November 20, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Piedmont Healthcare
March 12, 2009
March 13, 2009
November 20, 2017
February 2006
February 2012   (Final data collection date for primary outcome measure)
To assess the relationship of multiple phenotypes and genotypes with cardiovascular disease [ Time Frame: Yearly ]
Same as current
Complete list of historical versions of study NCT00861575 on ClinicalTrials.gov Archive Site
To assess the impact of phenotypes and genotypes of specific patient subgroups (gender, ethnic, family history) on cardiovascular disease [ Time Frame: Yearly ]
Same as current
Not Provided
Not Provided
 
Cardiogenomics Registry
CAD Genotype and Phenotype Cardiac Catheterization Laboratory Registry
This is a continuous blood banking study that will archive plasma and blood permitting DNA and plasma analysis at a future date. Subjects are recruited at the time of a clinically required procedure and blood samples are collected and banked and used for future research. The main purpose of this study is to investigate the interaction of multiple phenotypes and genotypes and their impact on cardiovascular disease events and measures of atherosclerosis progression.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
20 mL of blood are collected and aliquots of whole blood, plasma, serum and buffy coat are stored.
Non-Probability Sample
Subjects undergoing a clinical required cardiovascular procedure
Cardiovascular Disease
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
2601
February 2012
February 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • > 17 years of age
  • Undergoing a clinical required cardiovascular procedure
  • Agree to donation of blood sample
  • Provide written informed consent and Authorization for Use/Disclosure of PHI

Exclusion Criteria:

  • < 18 years of age
  • Refusal to donate a blood sample
  • Refusal to provide written informed consent and Authorization for Use/Disclosure of PHI
Sexes Eligible for Study: All
18 Years to 99 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00861575
PH05005
No
Not Provided
Not Provided
Piedmont Healthcare
Piedmont Healthcare
Not Provided
Principal Investigator: Sarah Rinehart, MD Piedmont Healthcare
Piedmont Healthcare
November 2017